Peroxisome proliferator-activated receptor agonists: do they increase cardiovascular risk?
Cardiovascular disease is a major cause of morbidity and mortality among people with type 2 diabetes mellitus. The peroxisome proliferator-activated receptor (PPAR) agonists have a significant role on glucose and fat metabolism. Thiazolidinediones (TZDs) are predominantly PPARγ agonists, and their primary benefit appears to be the prevention of diabetic complications by improving glycemic control and lipid profile. Recently, the cardiovascular safety of rosiglitazone was brought to center stage following meta analyses and the interim analysis of the RECORD trial. Current evidence points to rosiglitazone having a greater risk of myocardial ischemic events than placebo, metformin, or sulfonylureas. This review article discusses the mechanism of action of PPAR agonists and correlates it with clinical and laboratory outcomes in the published literature. In addition, this review article attempts to discuss some of the molecular mechanisms regarding the association between TZDs therapy and the nontraditional cardiovascular risks.
Aljada
Ahmad
A
Department of Biomedical Sciences, Long Island University-C.W.POST, Brookville, NY 11548, USA. ahmad.aljada@liu.edu
Shah
Kshitij Ashwin
KA
Mousa
Shaker A
SA
Diabetes Care. 2005 Jul;28(7):1547-54
15983299
Eur J Clin Pharmacol. 2003 Jul;59(3):189-93
12756509
J Clin Invest. 1996 Jun 1;97(11):2408-16
8647932
Circulation. 2000 Mar 21;101(11):1311-8
10725292
Am J Pathol. 1998 Jul;153(1):17-23
9665460
Diabetes Care. 2001 Mar;24(3):447-53
11289466
N Engl J Med. 1987 Nov 12;317(20):1237-45
3313041
Diabetologia. 2005 Sep;48(9):1726-35
16025252
JAMA. 1988 Aug 5;260(5):641-51
3164788
Arch Intern Med. 2002 Dec 9-23;162(22):2597-604
12456232
Atherosclerosis. 2004 Oct;176(2):327-35
15380456
J Clin Endocrinol Metab. 2001 Jul;86(7):3250-6
11443197
Circ Res. 1998 Nov 30;83(11):1097-103
9831704
N Engl J Med. 2006 Dec 7;355(23):2427-43
17145742
Arterioscler Thromb Vasc Biol. 2003 Apr 1;23(4):702-3
12692010
N Engl J Med. 2007 Jul 5;357(1):28-38
17551159
Lancet. 2005 Oct 8;366(9493):1279-89
16214598
JAMA. 2007 Sep 12;298(10):1189-95
17848653
Lancet. 2007 Sep 29;370(9593):1129-36
17905165
Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2428-34
17872455
JAMA. 2007 Dec 12;298(22):2634-43
18073359
Endocrinology. 1994 Aug;135(2):798-800
8033830
Circ Res. 2004 May 14;94(9):1168-78
15142970
Lancet. 2006 Sep 23;368(9541):1096-105
16997664
Lancet. 2005 Nov 26;366(9500):1849-61
16310551
J Clin Endocrinol Metab. 2001 Mar;86(3):1306-12
11238525
J Clin Endocrinol Metab. 2004 Jun;89(6):2728-35
15181049
J Biol Chem. 2002 Dec 13;277(50):48051-7
12377786
Arterioscler Thromb Vasc Biol. 2004 Oct;24(10):1789-95
15271788
N Engl J Med. 2007 Jun 14;356(24):2457-71
17517853
J Biol Chem. 2004 Apr 16;279(16):16154-60
14764586
J Biol Chem. 1998 Oct 2;273(40):25713-20
9748239
N Engl J Med. 2007 Jun 14;356(24):2522-4
17517854
Arch Intern Med. 2004 Oct 25;164(19):2097-104
15505122
Arterioscler Thromb Vasc Biol. 2006 Mar;26(3):624-30
16357312
Nature. 1998 Jan 1;391(6662):82-6
9422509
Biochem Biophys Res Commun. 2000 Jan 7;267(1):345-9
10623622
J Clin Pharm Ther. 2006 Aug;31(4):375-83
16882108
Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):182-8
16284192
Diabetes. 1998 Apr;47(4):507-14
9568680
EMBO J. 1996 Oct 1;15(19):5336-48
8895578
Am J Cardiol. 2002 Nov 1;90(9):947-52
12398960
N Engl J Med. 2008 Apr 10;358(15):1547-59
18378520
Lancet. 2008 Sep 27;372(9644):1174-83
18757085
Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):1897-902
15994444
JAMA. 2008 Apr 2;299(13):1561-73
18378631
J Endocrinol. 2001 Jun;169(3):453-9
11375115
Arterioscler Thromb Vasc Biol. 2006 Jan;26(1):28-40
16239592
Cerebrovasc Dis. 2008;26(2):106-12
18560212
J Biol Chem. 2001 Apr 20;276(16):12893-7
11278956
Vascul Pharmacol. 2007 Mar;46(3):188-94
17141574
Int J Clin Pharmacol Ther. 1998 Jun;36(6):345-9
9660044
Biochem Biophys Res Commun. 2000 Nov 30;278(3):704-11
11095972
Metabolism. 2005 Sep;54(9):1236-42
16125536
Lab Invest. 2009 Jan;89(1):47-58
19002105
Eur J Clin Invest. 2007 May;37(5):425-33
17461989
Diabetes Care. 1998 Sep;21(9):1414-31
9727886
Metabolism. 2004 Mar;53(3):330-4
15015145
Circulation. 2003 Feb 4;107(4):636-42
12566379
Cardiol Rev. 2005 Sep-Oct;13(5):240-6
16106185